Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.08 USD | -7.87% | -14.50% | -12.17% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 544M |
---|---|---|---|---|---|
Net income 2024 * | -123M | Net income 2025 * | -148M | EV / Sales 2024 * | - |
Net cash position 2024 * | 267M | Net cash position 2025 * | 153M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.42
x | P/E ratio 2025 * |
-4.09
x | Employees | 100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.47% |
Latest transcript on ORIC Pharmaceuticals, Inc.
1 day | -7.87% | ||
1 week | -14.50% | ||
Current month | -41.24% | ||
1 month | -41.91% | ||
3 months | -25.32% | ||
6 months | +47.99% | ||
Current year | -12.17% |
Managers | Title | Age | Since |
---|---|---|---|
Jacob Chacko
CEO | Chief Executive Officer | 45 | 18-05-06 |
Richard Heyman
FOU | Founder | 66 | 13-12-31 |
Director of Finance/CFO | 50 | 19-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Angie You
BRD | Director/Board Member | 51 | 21-11-08 |
Richard Heyman
FOU | Founder | 66 | 13-12-31 |
Mardi Dier
BRD | Director/Board Member | 60 | 20-03-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.48% | 4 M€ | -5.15% | - | |
0.03% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 8.08 | -7.87% | 374,439 |
24-04-23 | 8.77 | +0.57% | 270,485 |
24-04-22 | 8.72 | -5.11% | 315,162 |
24-04-19 | 9.19 | -3.36% | 668,037 |
24-04-18 | 9.51 | -2.56% | 589,783 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.17% | 591M | |
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |
- Stock Market
- Equities
- ORIC Stock